Aberrant H3K4me3 modification of immune response genes in CD4+ T cells of patients with systemic lupus erythematosus
- 2 March 2024
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 130, 111748
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- Chinese Academy of Fishery Sciences Central Public-interest Scientific Institution Basal Research Fund
This publication has 72 references indexed in Scilit:
- Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open‐label studyAmerican Journal of Hematology, 2022
- Proteomic profiling of saliva reveals association of complement system with primary Sjögren's syndromeImmunity, Inflammation and Disease, 2021
- Fostamatinib: First Global ApprovalDrugs, 2018
- Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trialsAmerican Journal of Hematology, 2018
- Blockade of Treg Cell Differentiation and Function by the Interleukin‐21–Mechanistic Target of Rapamycin Axis Via Suppression of Autophagy in Patients With Systemic Lupus ErythematosusArthritis & Rheumatology, 2018
- Effects of Fostamatinib, an Oral Spleen Tyrosine Kinase Inhibitor, in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate: Results From a Phase III, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group StudyArthritis & Rheumatology, 2014
- Genomic Pathology of SLE-Associated Copy-Number Variation at the FCGR2C/FCGR3B/FCGR2B LocusThe American Journal of Human Genetics, 2013
- Using the Reactome DatabaseCurrent Protocols in Bioinformatics, 2012
- Online Mendelian Inheritance In Man (OMIM)Human Mutation, 1999
- Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosusArthritis & Rheumatism, 1989